A Novel DHA Treatment Approach for Alzheimer's Disease
治疗阿尔茨海默病的新 DHA 方法
基本信息
- 批准号:10082124
- 负责人:
- 金额:$ 34.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAge-associated memory impairmentAgingAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAmericanBehavioralBiochemicalBlood - brain barrier anatomyBrainCertificationChemicalsChicagoClinical TrialsCollaborationsControl GroupsCyclic GMPDataDementiaDevelopmentDocosahexaenoic AcidsDrug Delivery SystemsEicosapentaenoic AcidElderlyEuphausiaceaFailureFish OilsFutureGenetic ModelsGoalsHumanIllinoisIndustryLeadLicensingLipaseLongevityLysophospholipidsMarketingMeasuresMemoryMemory LossMetabolicMusNatural ProductsOilsOmega-3 Fatty AcidsOutcomePeripheralPhasePopulationPreventionPreventivePreventive measurePreventive treatmentProcessProductionResearchSeriesTechniquesTestingTissuesTriglyceridesUniversitiesage relatedaging populationanalytical methodcognitive functioncommercializationdementia riskdietary supplementsearly onsetefficacy testingepidemiology studyexperienceexperimental studyfunctional declineimprovedinnovationmouse modelnovelnovel strategiesphase 2 studypreventprocess optimizationresearch and developmenttreatment effect
项目摘要
Alzheimer’s disease (AD) and related dementia (ADRD) are adversely impacting the healthy
lifespan in our aging population. Fish oil has been suggested to improve AD/ADRD outcomes.
The omega 3 fatty acids (Om3FA) in fish oil in particular DHA (docosahexaenoic acid) is a key
molecule. Some data exists that DHA is beneficial for protection against age related cognitive
decline and related dementia such as AD. However, current dietary supplements of Om3FA do
not appreciably increase DHA levels in the brain. Our data explains why multiple human clinical
trials failed with DHA treatment for preventing and/or treating AD/ADRD. We have discovered
that this failure to cross the blood-brain barrier is because the Om3FA from these supplements
are absorbed in the form of triacylglycerols, whereas the specific transporter (called Mfsd2a) at
the blood brain barrier requires a lysophospholipid (LPC) form of DHA. Because of this, when we
treat with lipase, it results in the LPC form of DHA. Then, when we treat mice with this form, mice
have a substantial enrichment of the brain DHA, as compared to control group and a notable
memory benefit. Thus, the goal of this phase 1 is to test if LPC-DHA effects memory in AD mouse
models. We will specifically explore the behavioral and biochemical effects of this treatment
approach. Through collaboration with the University of Illinois at Chicago, with expertise in
Om3FA and mouse models, and our expertise in chemical separation and Om3FA isolation
techniques, we are poised to test the efficacy of this novel treatment. Moreover, we are prepared
for Phase 2 studies, which will focus on development of pilot scale production/isolation processes of this
modified DHA. This will eventually lead to marketing and commercialization to protect and/or prevent
against AD development in Phase 3.
阿尔茨海默病(AD)和相关痴呆(ADRD)对健康人有不利影响,
在我们老龄化的人口中。鱼油已被建议改善AD/ADRD结果。
鱼油中的欧米茄3脂肪酸(Om 3FA),特别是DHA(二十二碳六烯酸)是一种关键的
分子。一些数据表明,DHA有助于防止与年龄相关的认知障碍。
衰退和相关的痴呆症,如AD。然而,目前Om 3FA的膳食补充剂
不会明显增加大脑中的DHA水平。我们的数据解释了为什么多个人类临床
DHA治疗预防和/或治疗AD/ADRD试验失败。我们已经发现
这种无法穿过血脑屏障的现象是因为这些补充剂中的Om 3FA
以三酰甘油的形式被吸收,而特定的转运蛋白(称为Mfsd 2a),
血脑屏障需要溶血磷脂(LPC)形式的DHA。因此,当我们
用脂肪酶处理,它导致LPC形式的DHA。然后,当我们用这种形式治疗小鼠时,小鼠
与对照组相比,
记忆的好处因此,该阶段1的目标是测试LPC-DHA是否影响AD小鼠的记忆
模型我们将特别探讨这种治疗的行为和生化影响
approach.通过与伊利诺伊大学芝加哥分校合作,
Om 3FA和小鼠模型,以及我们在化学分离和Om 3FA分离方面的专业知识
技术,我们准备测试这种新疗法的疗效。此外,我们准备
第2阶段研究,重点是开发中试规模的生产/分离工艺,
改性DHA这将最终导致市场营销和商业化,以保护和/或防止
在第三阶段对抗AD的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Thomas Layden其他文献
Brian Thomas Layden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Thomas Layden', 18)}}的其他基金
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
非裔美国人和西班牙裔人急性胰腺炎导致糖尿病的机制
- 批准号:
10461069 - 财政年份:2020
- 资助金额:
$ 34.96万 - 项目类别:
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
非裔美国人和西班牙裔人急性胰腺炎导致糖尿病的机制
- 批准号:
10513167 - 财政年份:2020
- 资助金额:
$ 34.96万 - 项目类别:
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
非裔美国人和西班牙裔人急性胰腺炎导致糖尿病的机制
- 批准号:
10449719 - 财政年份:2020
- 资助金额:
$ 34.96万 - 项目类别:
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
非裔美国人和西班牙裔人急性胰腺炎导致糖尿病的机制
- 批准号:
10671693 - 财政年份:2020
- 资助金额:
$ 34.96万 - 项目类别:
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
非裔美国人和西班牙裔人急性胰腺炎导致糖尿病的机制
- 批准号:
10265550 - 财政年份:2020
- 资助金额:
$ 34.96万 - 项目类别:
Role of Nutrient Sensing Receptors for the Gut Microbiota in Metabolism
肠道菌群营养感应受体在代谢中的作用
- 批准号:
10535442 - 财政年份:2017
- 资助金额:
$ 34.96万 - 项目类别:
A Novel Relationship Between the Gut Microbiota and Pancreatic Beta Cells contributes to Gestational Glucose Homeostasis
肠道微生物群和胰腺β细胞之间的新关系有助于妊娠血糖稳态
- 批准号:
9898235 - 财政年份:2017
- 资助金额:
$ 34.96万 - 项目类别:
A Novel Relationship Between the Gut Microbiota and Pancreatic Beta Cells contributes to Gestational Glucose Homeostasis
肠道微生物群和胰腺β细胞之间的新关系有助于妊娠血糖稳态
- 批准号:
9349855 - 财政年份:2017
- 资助金额:
$ 34.96万 - 项目类别:
Role of Nutrient Sensing Receptors for the Gut Microbiota in Metabolism
肠道菌群营养感应受体在代谢中的作用
- 批准号:
10364023 - 财政年份:2017
- 资助金额:
$ 34.96万 - 项目类别:
The function and regulation of the novel pregnancy-specific hexokinase HKDC1
新型妊娠特异性己糖激酶HKDC1的功能与调控
- 批准号:
10119096 - 财政年份:2015
- 资助金额:
$ 34.96万 - 项目类别:
相似海外基金
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7606738 - 财政年份:2007
- 资助金额:
$ 34.96万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7717960 - 财政年份:2007
- 资助金额:
$ 34.96万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7205360 - 财政年份:2004
- 资助金额:
$ 34.96万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6305687 - 财政年份:1999
- 资助金额:
$ 34.96万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6115572 - 财政年份:1998
- 资助金额:
$ 34.96万 - 项目类别:
A study on the biological features of age-associated memory impairment (AAMI).
年龄相关记忆障碍(AAMI)生物学特征的研究。
- 批准号:
09671003 - 财政年份:1997
- 资助金额:
$ 34.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C).
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6276806 - 财政年份:1997
- 资助金额:
$ 34.96万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386469 - 财政年份:1990
- 资助金额:
$ 34.96万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386468 - 财政年份:1990
- 资助金额:
$ 34.96万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
2247160 - 财政年份:1990
- 资助金额:
$ 34.96万 - 项目类别: